Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 17
186
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Three new compounds with their anti-glioma effects from the roots of Arnebia guttata Bunge

, , ORCID Icon, , , & show all
Pages 2817-2823 | Received 04 Mar 2022, Accepted 07 Oct 2022, Published online: 20 Oct 2022
 

Abstract

Three new compounds, arneatas A-C (13), together with three known compounds (46) were isolated from the roots of Arnebia guttata Bunge. The structures were established on the basis of extensive spectroscopic data including NMR and HRESIMS. All the new compounds (13) were tested for their cytotoxic activity against two glioma cell lines (U118-MG and U373-MG) in vitro after treatment for 48 h. Compound 1 exhibited moderate cytotoxic activity against U118-MG and U373-MG glioma cell lines, with IC50 values of 10.4 and 17.5 µM, respectively.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The key project at central government level: the ability establishment of sustainable use for valuable Chinese medicine resources No: 2060302 Graduate student scientific research innovation projects in Baotou Medical College No: bycx2021010 Inner Mongolia Autonomous Region Chinese Medicine (Mongolian Medicine) Young and Middle aged Leading Talents Cultivation Project NO: 2022-[RC001] This work was supported by the key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources under Grant [No: 2060302]; Graduate student scientific research innovation projects in Baotou Medical College [No: bycx2021010]; Inner Mongolia Autonomous Region Chinese Medicine (Mongolian Medicine) Young and Middle aged Leading Talents Cultivation Project NO: 2022-[RC001]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.